Bustamante, C.; DÃez-MejÃa, A.F.; Arbeláez, N.; Soares, M.J.; Robledo, S.M.; Ochoa, R.; Varela-M., R.E.; MarÃn-Villa, M.
In Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, a Potential Novel Compound for Treating against Trypanosoma cruzi. Pathogens 2022, 11, 616.
https://doi.org/10.3390/pathogens11060616
AMA Style
Bustamante C, DÃez-MejÃa AF, Arbeláez N, Soares MJ, Robledo SM, Ochoa R, Varela-M. RE, MarÃn-Villa M.
In Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, a Potential Novel Compound for Treating against Trypanosoma cruzi. Pathogens. 2022; 11(6):616.
https://doi.org/10.3390/pathogens11060616
Chicago/Turabian Style
Bustamante, Christian, Andrés Felipe DÃez-MejÃa, Natalia Arbeláez, Maurilio José Soares, Sara M. Robledo, Rodrigo Ochoa, Rubén E. Varela-M., and Marcel MarÃn-Villa.
2022. "In Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, a Potential Novel Compound for Treating against Trypanosoma cruzi" Pathogens 11, no. 6: 616.
https://doi.org/10.3390/pathogens11060616
APA Style
Bustamante, C., DÃez-MejÃa, A. F., Arbeláez, N., Soares, M. J., Robledo, S. M., Ochoa, R., Varela-M., R. E., & MarÃn-Villa, M.
(2022). In Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, a Potential Novel Compound for Treating against Trypanosoma cruzi. Pathogens, 11(6), 616.
https://doi.org/10.3390/pathogens11060616